Delineate
Delineate is a YC Winter 2025 (W25) company. Based in Boston, MA, USA; Remote. Team of 20.
About Delineate
Summary
Delineate builds AI agents that design clinical trials for pharmaceutical companies. The agents process existing trial research into specialized datasets, replacing months of manual work by scientists. The result is faster trial design and progression through trial phases.
Go-to-market
Large pharmaceutical companies are the primary buyers, engaged through a direct sales process targeting trial design and data compilation workflows.
From the Y Combinator listing
Agents for Accelerated Clinical Trial Design
Delineate is building AI agents to design better clinical trials faster. This is a $10B dollar market, where saving even 1 day along the process is equal to $1-5M in revenue potential. We process existing clinical trial research into specialized datasets saving scientists months of effort. Delineate is working with two of the largest pharmaceutical companies. With one of our customers, we are helping them get to the next phase of trials faster by creating the largest dataset on a drug class ever constructed.
Facts
- B2B / B2B -> Engineering, Product and Design
- Boston, MA, USA; Remote
- 20
- Active
- Early
Founders (1)
- Jawad Iqbal
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works